Clinical trial
A National, Multi-Center, Open-Label Study of Velcade in Combination With Melphalan and Prednisone (V-MP) in Older Untreated Multiple Myeloma Patients.
NCT00388635 is registered in ClinicalTrials.gov with PETHEMA Foundation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A National, Multi-Center, Open-Label Study of Velcade in Combination With Melphalan and Prednisone (V-MP) in Older Untreated Multiple Myeloma Patients.
- Lead sponsor
- PETHEMA Foundation
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- April 30, 2004
- Completion date
- December 31, 2008
- Enrollment
- 60 (actual)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.